Astec LifesciencesNSE:ASTEC -3.52%75 PB Ratio is 4.14 as of Jun. 26, 2026, which is 39% below its 10-year median of 6.80. GuruFocus rates NSE:ASTEC with a GF Score™ of 75/100 and a GF Value™ of ₹976.08 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 249 Agriculture companies, Astec Lifesciences ranks worse than 88.35% on this metric.
The historical rank and industry rank for Astec Lifesciences's PB Ratio or its related term are showing as below:
NSE:ASTEC'
s PB Ratio Range Over the Past 10 Years
Min: 3.09 Med: 6.8 Max: 10.06
Current: 4.14
During the past 13 years, Astec Lifesciences's highest PB Ratio was 10.06. The lowest was 3.09. And the median was 6.80.
NSE:ASTEC's PB Ratio is ranked worse than 88.35% of 249
companies
in the Agriculture industry
Industry Median: 1.51
vs NSE:ASTEC: 4.14
During the past 12 months, Astec Lifesciences's average Book Value Per Share Growth Rate was 47.60% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -6.20% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -3.20% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 11.20% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Astec Lifesciences was 33.30% per year. The lowest was -16.10% per year. And the median was 9.80% per year.
Back to Basics: PB Ratio
Astec Lifesciences (NSE:ASTEC) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Astec Lifesciences PB Ratio Related Terms
Astec Lifesciences PB Ratio Historical Data
* Premium members only.
The historical data trend for Astec Lifesciences's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Agricultural Inputs subindustry, Astec Lifesciences's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Astec Lifesciences PB Ratio vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, Astec Lifesciences's PB Ratio distribution charts can be found below:
* The bar in red indicates where Astec Lifesciences's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Astec Lifesciences (NSE:ASTEC) has a PB Ratio of 4.14 as of Jun. 26, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Astec Lifesciences and its competitors. This is 39% below median its historical median of 6.80. Over the past decade, Astec Lifesciences' PB Ratio has ranged from 3.09 to 10.06. According to the industry distribution chart, Astec Lifesciences ranks #220 out of 249 companies in the Agriculture industry, placing it in the top 88.4%.
Is Astec Lifesciences' PB Ratio too high?
Astec Lifesciences' current PB Ratio of 4.14 is 39% below median its 10-year median of 6.80. Over the past 10 years, this metric has ranged from a low of 3.09 to a high of 10.06. The Agriculture industry median PB Ratio is 1.51. Astec Lifesciences' value of 4.14 is 174.2% above this industry median. Based on the distribution chart, Astec Lifesciences ranks #220 out of 249 companies in the Agriculture industry, which is in the bottom quartile relative to peers. Overall, Astec Lifesciences has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Astec Lifesciences' PB Ratio compare to CTVA and CF?
According to the Agriculture industry distribution chart, Astec Lifesciences ranks #220 out of 249 companies for PB Ratio. This places Astec Lifesciences in the lower half of its industry. The industry median PB Ratio is 1.51. Astec Lifesciences' value of 4.14 is 174.2% above this benchmark. Historically, Astec Lifesciences' own PB Ratio has ranged from 3.09 to 10.06 over the past decade. While the company's 10-year median is 6.80 vs. the industry median of 1.51, Astec Lifesciences has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for an Agriculture company?
The median PB Ratio among Agriculture companies is 1.51, based on 249 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Astec Lifesciences's current PB Ratio of 4.14 is 174.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Astec Lifesciences and its competitors. For the Agriculture industry, the median PB Ratio is 1.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Astec Lifesciences's current PB Ratio is 4.14, which is 39% below median its own 10-year median of 6.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Astec Lifesciences stock overvalued right now?
Based on GuruFocus' analysis, Astec Lifesciences (NSE:ASTEC) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹976.08, compared to a current price of ₹725.45 — trading 25.7% below its estimated fair value. The current PB Ratio is 4.14, which is 39% below median its 10-year median of 6.80 and 174.2% above the Agriculture industry median of 1.51. Astec Lifesciences' overall GF Score™ is 75/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Astec Lifesciences (NSE:ASTEC), the current PB Ratio is 4.14 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Astec Lifesciences (NSE:ASTEC) Overvalued in 2026?
Based on GuruFocus' analysis, Astec Lifesciences stock appears to be undervalued.
The current stock price of ₹725.45 is trading 25.7% below its estimated GF Value™ of ₹976.08.
GuruFocus considers Astec Lifesciences to be Modestly Undervalued.
Key valuation signals for NSE:ASTEC:
PB Ratio: 4.14 (39% below median its 10-year median of 6.80)
GF Value™: ₹976.08 vs. price of ₹725.45 (25.7% below fair value)
Industry Position: 174.2% above the Agriculture median (#220 of 249)
No single metric tells the full story. See the NSE:ASTEC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Astec Lifesciences Ltd manufactures & distributes a wide range of Agrochemical active ingredients and pharmaceutical intermediates. The company's products include agrochemicals, such as Triazole Fungicides, Herbicides, and Insecticides. The company is also into Intermediates & Specialty chemicals. Geographically, all the operations of the firm function through India; however, its products are sold in the Indian and overseas markets. It operates in the business segment of Agrochemicals and has a business presence in India and outside India.
75GF Score
Get the complete analysis for NSE:ASTEC
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ASTEC has been successfully added to your 
